Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of MAD2L1BP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 774.61 | 1445 / 1445 | 100% | 37.74 | 183 / 183 |
ovary | 100% | 508.74 | 180 / 180 | 100% | 35.38 | 430 / 430 |
skin | 100% | 972.70 | 1809 / 1809 | 100% | 93.25 | 472 / 472 |
stomach | 100% | 816.66 | 359 / 359 | 100% | 45.11 | 286 / 286 |
breast | 100% | 763.92 | 459 / 459 | 100% | 49.46 | 1116 / 1118 |
intestine | 100% | 989.99 | 966 / 966 | 100% | 53.06 | 526 / 527 |
uterus | 100% | 618.90 | 170 / 170 | 100% | 49.00 | 458 / 459 |
liver | 100% | 568.81 | 226 / 226 | 100% | 32.00 | 405 / 406 |
thymus | 100% | 741.87 | 653 / 653 | 100% | 36.40 | 603 / 605 |
lung | 99% | 690.26 | 575 / 578 | 100% | 43.18 | 1155 / 1155 |
bladder | 100% | 692.67 | 21 / 21 | 99% | 49.09 | 501 / 504 |
prostate | 100% | 643.00 | 245 / 245 | 99% | 36.29 | 499 / 502 |
kidney | 100% | 701.22 | 89 / 89 | 99% | 30.63 | 894 / 901 |
brain | 99% | 623.37 | 2610 / 2642 | 100% | 38.20 | 705 / 705 |
pancreas | 98% | 463.87 | 322 / 328 | 100% | 38.98 | 178 / 178 |
adrenal gland | 100% | 901.94 | 258 / 258 | 97% | 36.95 | 222 / 230 |
adipose | 100% | 765.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 54.89 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 59.35 | 29 / 29 |
muscle | 100% | 918.81 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 992.02 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 48.13 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.86 | 1 / 1 |
blood vessel | 100% | 547.16 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 727.64 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 937.10 | 900 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007096 | Biological process | regulation of exit from mitosis |
GO_1902426 | Biological process | deactivation of mitotic spindle assembly checkpoint |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005819 | Cellular component | spindle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | MAD2L1BP |
Protein name | MAD2L1-binding protein (Caught by MAD2 protein) (p31(comet)) |
Synonyms | KIAA0110 CMT2 |
Description | FUNCTION: May function to silence the spindle checkpoint and allow mitosis to proceed through anaphase by binding MAD2L1 after it has become dissociated from the MAD2L1-CDC20 complex. . |
Accessions | ENST00000372171.5 [Q15013-1] ENST00000451025.6 [Q15013-3] Q15013 |